Epicore BioNetworks Inc. on Focus After Raising In Today’s Session

 Epicore BioNetworks Inc. on Focus After Raising In Today's Session

The stock of Epicore BioNetworks Inc. (CVE:EBN) is a huge mover today! About 29,400 shares traded hands or 225.37% up from the average. Epicore BioNetworks Inc. (CVE:EBN) has risen 6.00% since October 1, 2016 and is uptrending. It has outperformed by 2.53% the S&P500.
The move comes after 6 months positive chart setup for the $13.81M company. It was reported on Oct, 31 by Barchart.com. We have $1.05 PT which if reached, will make CVE:EBN worth $11.74M more.

More notable recent Epicore BioNetworks Inc. (CVE:EBN) news were published by: Finance.Yahoo.com which released: “Epicore BioNetworks Inc. Announces Corporate Actions” on September 28, 2016, also Prnewswire.com with their article: “Epicore BioNetworks Inc. Reports Results for Fiscal Year 2016” published on October 07, 2016, Prnewswire.com published: “Epicore BioNetworks Inc. Reports Second Quarter Results for Fiscal Year 2016” on February 23, 2016. More interesting news about Epicore BioNetworks Inc. (CVE:EBN) were released by: Globenewswire.com and their article: “Epicore BioNetworks Inc. Announces New Regional Manager” published on November 20, 2014 as well as Prnewswire.com‘s news article titled: “Epicore BioNetworks Inc. Strong Quarter Two Fiscal Year 2012” with publication date: February 28, 2012.

Epicore Bionetworks Inc. designs, develops and makes biotechnology, biochemical and nutrition products, as well as specialty animal feeds. The company has a market cap of $13.81 million. The Company’s divisions include Aquaculture, Agriculture and Municipal. It has a 8.82 P/E ratio. The Company’s product lines are based on natural microbes and enzymes, and include applications in aquaculture, agriculture and waste water treatment, bioremediation and cleaning.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment